A shadow economy for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Treatment Gaining Traction Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Followers are encouraged to message these accounts privately for source information, while also obtaining discount codes.
Active Trade on Social Networks
Additionally, a robust trade exists on messaging services, where communities with numerous of participants share comparison photos, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
However, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.
Some professionals said the popularity for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, risking fines, legal action or prison.
Platform Response and Content Elimination
According to TikTok, the service has removed violative content and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Investigations also found groups with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of members, populated with photos of slimming results, positive reviews and step-by-step instructions for preparing or administering at residence.
After moments of joining one community, a vendor posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or past usage.
Product Information and Costs
Within these groups, posts show black plastic packages with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens usually priced at £160 for 20mg. When asked how long a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service said it regularly moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting materials they cannot confirm. Even if the research behind this drug is sound, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has previously seen individuals injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may subject users to potentially significant health risks”.
